Sildenafil Citrate
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Duke University
Overview
Sildenafil Citrate is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Sildenafil Citrate clinical trials
Explore related
Medical disclaimer. This page summarizes research about Sildenafil Citrate for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.